Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSC vs Triamcinolone for Keloids (Pilot)
NCT04553159Phase 2Completed
- Sponsor
- Makerere University
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in keloid, sponsored by Makerere University. Started Mar 2021; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04553159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553159.